Anna Smed-Sorensen

Summary

Affiliation: Huddinge University Hospital
Country: Sweden

Publications

  1. ncbi HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation
    Anna Smed-Sorensen
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, F59 Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Blood 104:2810-7. 2004
  2. ncbi Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells
    Anna Smed-Sorensen
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, F59 Huddinge University Hospital, S 141 86 Stockholm, Sweden
    J Virol 79:8861-9. 2005
  3. ncbi Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells
    Johan Söderlund
    Infectious Diseases Unit, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden
    AIDS Res Hum Retroviruses 23:101-6. 2007
  4. ncbi IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa
    Anna Smed-Sorensen
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Blood 111:5037-46. 2008
  5. ncbi IFN-? produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiation
    Cornelia Gujer
    Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden
    J Leukoc Biol 89:811-21. 2011
  6. ncbi Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments
    Markus Moll
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Blood 116:1876-84. 2010
  7. ncbi Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs
    Ulrika Johansson
    Department of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    J Immunol 179:1711-20. 2007
  8. ncbi Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations
    Emily Bond
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    J Invest Dermatol 132:114-23. 2012
  9. ncbi Dendritic cells at the interface of innate and adaptive immunity to HIV-1
    Anna Smed-Sorensen
    Department of Microbiology, Tumor and Cell Biology bCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Curr Opin HIV AIDS 6:405-10. 2011
  10. ncbi Techniques for time-efficient isolation of human skin dendritic cell subsets and assessment of their antigen uptake capacity
    Emily Bond
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    J Immunol Methods 348:42-56. 2009

Collaborators

Detail Information

Publications10

  1. ncbi HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation
    Anna Smed-Sorensen
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, F59 Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
    Blood 104:2810-7. 2004
    ..These observations suggest that HIV-1 infection disables DC function, a phenomenon that may be relevant for optimal induction of HIV-1-specific immune responses...
  2. ncbi Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells
    Anna Smed-Sorensen
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, F59 Huddinge University Hospital, S 141 86 Stockholm, Sweden
    J Virol 79:8861-9. 2005
    ..The difference in susceptibility of PDCs and MDCs to HIV-1 may have implications for HIV-1 transmission and DC-mediated transfer of HIV-1 to T cells...
  3. ncbi Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells
    Johan Söderlund
    Infectious Diseases Unit, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden
    AIDS Res Hum Retroviruses 23:101-6. 2007
    ..However, they readily neutralized HIV-1 infection of PBMC alone. This may suggest that protection against HIV-1 infection in HEPS individuals occurs prior to interaction between HIV-1-exposed DC and other target cells...
  4. ncbi IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa
    Anna Smed-Sorensen
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Blood 111:5037-46. 2008
    ..Our data demonstrate an important role for FcgammaRIIa in regulating the CD1 antigen presentation machinery of human DCs...
  5. ncbi IFN-? produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiation
    Cornelia Gujer
    Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden
    J Leukoc Biol 89:811-21. 2011
    ..In summary, PDCs, via their production of IFN-?, may render B cells more responsive to T cell contact, which in turn, facilitates B cell proliferation and differentiation to antibody-producing cells...
  6. ncbi Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments
    Markus Moll
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Blood 116:1876-84. 2010
    ....
  7. ncbi Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs
    Ulrika Johansson
    Department of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
    J Immunol 179:1711-20. 2007
    ..Together, these findings show that activated apoptotic PBMCs per se provide an activation/maturation signal to DCs, suggesting that activated apoptotic PBMCs possess endogenous adjuvant properties...
  8. ncbi Plasmacytoid dendritic cells infiltrate the skin in positive tuberculin skin test indurations
    Emily Bond
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    J Invest Dermatol 132:114-23. 2012
    ....
  9. ncbi Dendritic cells at the interface of innate and adaptive immunity to HIV-1
    Anna Smed-Sorensen
    Department of Microbiology, Tumor and Cell Biology bCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    Curr Opin HIV AIDS 6:405-10. 2011
    ..This review summarizes recent findings on how HIV-1 infection affects dendritic cells in their ability to elicit innate and adaptive immune responses...
  10. ncbi Techniques for time-efficient isolation of human skin dendritic cell subsets and assessment of their antigen uptake capacity
    Emily Bond
    Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    J Immunol Methods 348:42-56. 2009
    ..These methods offer potency for various applications addressing antigen uptake, microbial DC interactions or other antigenic stimulation targeting the skin and can enhance our knowledge of basic DC biology in human skin...